跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRINOTECAN WOCKHARDT irinotecan hydrochloride 100mg/5mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
IRINOTECAN WOCKHARDT irinotecan hydrochloride 100mg/5mL injection vial
Approved
STANDARD
IRINOTECAN WOCKHARDT irinotecan hydrochloride 100mg/5mL injection vial
Wockhardt Bio Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
364e862b820d47ed
Company
Wockhardt Bio Pty Ltd
Type
Standard
Approval Details
Approval Id
364e862b820d47ed
Product Name
IRINOTECAN WOCKHARDT irinotecan hydrochloride 100mg/5mL injection vial
Artg Id
272856
Artg Name
IRINOTECAN WOCKHARDT irinotecan hydrochloride 100mg/5mL injection vial
Sponsor
Wockhardt Bio Pty Ltd
Company Detail Path
/organization/wockhardt-bio-pty-ltd
Artg Date
2017-10-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-CMI-02570-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
364e862b820d47ed
Type
Standard
Back to TGA Approvals